Page last updated: 2024-09-05

eslicarbazepine acetate and apremilast

eslicarbazepine acetate has been researched along with apremilast in 1 studies

Compound Research Comparison

Studies
(eslicarbazepine acetate)
Trials
(eslicarbazepine acetate)
Recent Studies (post-2010)
(eslicarbazepine acetate)
Studies
(apremilast)
Trials
(apremilast)
Recent Studies (post-2010) (apremilast)
2296817561996586

Protein Interaction Comparison

ProteinTaxonomyeslicarbazepine acetate (IC50)apremilast (IC50)
cAMP-specific 3',5'-cyclic phosphodiesterase 4AHomo sapiens (human)0.086
cAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)0.059
cAMP-specific 3',5'-cyclic phosphodiesterase 4CHomo sapiens (human)0.086
cAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)0.1235

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hussar, DA1

Other Studies

1 other study(ies) available for eslicarbazepine acetate and apremilast

ArticleYear
New drugs 2015, part 1.
    Nursing, 2015, Volume: 45, Issue:4

    Topics: Benzhydryl Compounds; Benzyl Alcohols; Chlorobenzenes; Dibenzazepines; Drug Approval; Estrogens, Conjugated (USP); Glucosides; Humans; Indoles; Nitriles; Pyridones; Pyrimidines; Quinuclidines; Thalidomide; United States; United States Food and Drug Administration

2015